Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Open-label, Multi-Centre, Phase IV Study Assessing the Effect of Oseltamivir Treatment on Cognitive Function in Subjects With Confirmed Influenza Virus Infection

NCT01249833 is registered in ClinicalTrials.gov with Trial Management Group Inc. as lead sponsor.

NCT NCT01249833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01249833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Open-label, Multi-Centre, Phase IV Study Assessing the Effect of Oseltamivir Treatment on Cognitive Function in Subjects With Confirmed Influenza Virus Infection
Lead sponsor
Trial Management Group Inc.
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2010
Completion date
April 30, 2012
Enrollment
122 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

influenza